Comviva, a global leader in customer experience and data monetization solutions today announced the launch of its 5G compatible Application Driven Network Platform, ADriN to offer a unified, simplified, secured experience to the B2B2X value chain of ...
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. today announced the launch of Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of the reference listed drug Butalbital, Acetaminophen, and C ...
Senores Pharmaceuticals, Inc. announced the launch of Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg, a therapeutic equivalent version of MEXITIL (Mexiletine Hydrochloride) with one of the top 5 generic pharmaceutical companies in t ...
Cintex Services, LLC and Senores Pharmaceuticals, Inc. announce the launch of Chlorzoxazone Tablets USP, 250 mg, a therapeutic equivalent version of Paraflex (Chlorzoxazone) 250 mg in the US market. The product will be distributed by Cintex Services, ...
